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Background
Cofactors may contribute to the elicitation and severity
of anaphylaxis in about 30% of anaphylactic reactions.
Clinical data from registries can support the identifica-
tion and risk impact of such cofactors. Besides exercise
or alcohol, drugs are known to facilitate anaphylactic
reactions. The facilitating effect of cardiovascular drugs
to hymenoptera stings is controversially discussed; data
on the association of cardiovascular drugs and anaphy-
laxis due to other elicitors are not available.
Objective
To assess whether cardiovascular drugs like beta-block-
ers and angiotensin-converting enzyme (ACE)-inhibitors
alter the risk for severe anaphylaxis.
Methods
Data from the German-speaking anaphylaxis registry were
collected from January 2006 to March 2013 and analysed.
The impact of beta-blockers and/or ACE-inhibitors on the
severity of anaphylaxis was calculated by using a logistic
regression model.
Results
The statistical analysis showed an elevated risk of
severe anaphylaxis (grade I/II n=2355 versus grade III/IV
n=1686) in patients with beta-blocker or ACE-inhibitor
treatment (odds ratios (OR): monotherapy with ACE-inhi-
bitor 1.37 [0.94-1.98], monotherapy with beta-blocker 1.36
[1.09-1.72], p-value = 0.008 to patient without contribu-
tion of cofactors), which was more pronounced when both
drugs were taken (OR: combined therapy with ACE-inhi-
bitor/beta-blocker 1.70 [1.28-2.26], p-value <0.001). These
findings were more prominent if grade I-III versus very
severe reactions (grade IV; OR: drug combination 2.44
[1.31-4.53], p-value = 0.005) were calculated. Adjustment
of sex and age reduced the OR, however, the results still
indicate clinical relevant effect sizes (OR: drug combina-
tion 2.07 [1.04-4.12]). The effects were independent of the
type of elicitor (food, drug, insect stings and others) of the
anaphylactic reaction.
Conclusion
Our data show that patients treated with beta-blockers
and/or ACE-inhibitors have an increased risk to develop
more severe anaphylactic symptoms. Interestingly, both
drugs seem to synergistically aggravate the anaphylaxis.
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